by What is the Stem Cell Therapy for Neurological Disorders Market Size?
The global stem cell therapy for neurological disorders market was valued at USD 2.38 billion in 2025 and is projected to grow from USD 2.81 billion in 2026 to approximately USD 12.67 billion by 2035, registering a CAGR of 17.90% during the forecast period from 2026 to 2035.
Key Takeaways
- North America led the stem cell therapy for neurological disorders market in 2025 with a 41% share.
- Asia Pacific is expected to grow at the fastest CAGR of 21.4% between 2026 and 2035.
- By cell type, the mesenchymal stem cells (MSCs) segment led the market with a 42% share in 2025.
- By cell type, the induced pluripotent stem cells (iPSCs) segment is expected to grow at the fastest CAGR of 22.4% in the upcoming period.
- By disorder type, the Alzheimer’s disease segment held a market share of 24% in 2025 and is expected to grow at the fastest CAGR of 19.6% during the projection period.
Stem Cell Therapy for Neurological Disorders Market Overview
The stem cell therapy for neurological disorders market focuses on the development and application of stem cell-based treatments for neurological diseases and damaged nervous system tissues. Stem cells possess the unique ability to self-renew and differentiate into specialized cell types, including neural cells, making them highly suitable for regenerative therapies.
These therapies offer significant therapeutic benefits through mechanisms such as cell replacement, immunomodulation, paracrine signaling, and the activation of the body’s natural repair processes. As a result, stem cell-based treatments are increasingly gaining attention as a promising approach for managing and potentially improving outcomes in a wide range of neurological disorders.
Market Regional Analysis: North America, Europe, Asia-Pacific
What is the North America Stem Cell Therapy for Neurological Disorders Market Size?
The North America stem cell therapy for neurological disorders market was valued at USD 0.98 billion in 2025 and is expected to grow to approximately USD 4.57 billion by 2035, expanding at a CAGR of 16.20% during the forecast period from 2026 to 2035.
